Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer
BackgroundImmune checkpoint inhibitors (ICIs) have demonstrated efficacy in the treatment of resectable and advanced gastric cancer. However, their effectiveness in initially unresectable gastric cancer remains unclear. This study aims to evaluate the …